These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12580839)

  • 21. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
    Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
    J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization.
    Gibreel A; Maheshwari A; Bhattacharya S
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008528. PubMed ID: 23152261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET.
    Fouda UM; Sayed AM
    Gynecol Endocrinol; 2011 Dec; 27(12):1018-22. PubMed ID: 21714697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Revisiting the clomifene-gonadotropin protocol in IVF with the use of a GnRH antagonist].
    Emperaire JC; Parneix I; Perraguin-Jayot S
    Gynecol Obstet Fertil; 2003 Nov; 31(11):927-31. PubMed ID: 14623556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of HCG in IVF Treatment: Does it depend on age or on protocol?
    Theofanakis C; Athanasiou V; Liokari E; Stavrou S; Sakellariou M; Athanassiou AI; Athanassiou A; Drakakis P; Loutradis D
    J Gynecol Obstet Hum Reprod; 2019 May; 48(5):341-345. PubMed ID: 30794953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve.
    Yu R; Jin H; Huang X; Lin J; Wang P
    J Int Med Res; 2018 Jun; 46(6):2327-2337. PubMed ID: 29695208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA; El Din RE
    Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, cetrorelix, and GnRH agonists.
    Nikolettos N; Al-Hasani S; Felberbaum R; Demirel LC; Riethmüller-Winzen H; Reissmann T; Schöpper B; Sturm R; Diedrich K
    Eur J Obstet Gynecol Reprod Biol; 2000 Nov; 93(1):91-5. PubMed ID: 11000511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
    Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
    Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol.
    Takahashi K; Mukaida T; Tomiyama T; Goto T; Oka C
    J Assist Reprod Genet; 2004 Sep; 21(9):317-22. PubMed ID: 15587144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
    Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
    Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cumulative live birth rate and cost-effectiveness of the clomiphene and gonadotropin cotreatment protocol versus the mid-luteal GnRH agonist protocol in women over 35 years old.
    Li Y; Luo D; Li T; Ding H; Liu Y
    Sci Rep; 2024 Jun; 14(1):12894. PubMed ID: 38839827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?
    Craft I; Gorgy A; Hill J; Menon D; Podsiadly B
    Hum Reprod; 1999 Dec; 14(12):2959-62. PubMed ID: 10601078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of estradiol patterns in clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol.
    Lin YH; Seow KM; Chen HJ; Huang LW; Hwang JL; Tzeng CR
    Gynecol Endocrinol; 2007 Jan; 23(1):45-9. PubMed ID: 17484512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study.
    Wei LH; Ma WH; Tang N; Wei JH
    Taiwan J Obstet Gynecol; 2016 Feb; 55(1):50-4. PubMed ID: 26927248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.